Is femtosecond LASIK the best option?

Article

A comparative analysis between manual and automated surgery

Initially, flap creation was performed by means of mechanical microkeratomes, with the inconvenience of the generation of flaps that were thinner in the centre than in the periphery, (meniscus-shaped configuration).2 This meniscus of tissue behaved as an additional optical element of the ocular system, inducing new higher order aberrations and modifying the predictability of the second order correction.3

Improvements in mechanical microkeratomes aimed at providing flaps with a more homogeneous thickness profile (planar flap configuration) and of less thickness to leave a thicker stromal residual bed have been developed and introduced in the clinical setting in the last few years. Likewise, femtosecond lasers for LASIK have been also introduced, which are now considered as a significant advancement for corneal laser refractive surgery.4 This type of photodisruptive laser that uses an infrared Nd:Glass laser beam (wavelength 1053 nm) allows the surgeon to program flap creation at a predetermined depth with a high degree of precision.

Our clinical experience

The clinical histories of all patients that had undergone LASIK surgery in our centre since May 2000 were retrospectively reviewed. A total of 13000 surgical procedures had been performed with the mechanical microkeratome Hansatome (Bausch + Lomb, Rochester, New York, USA) and 2000 procedures with the Amadeus microkeratome (Ziemer Ophthalmic Systems, Port, Switzerland). A total of 800 LASIK procedures had been performed with the IntraLase iFS femtosecond technology (Abbott Medical Optics, Santa Ana, California, USA) since January 2011.

According to the clinical guidelines of our centre, a complete preoperative ophthalmological examination had been performed in all cases to evaluate the viability of the corneal surgical procedure. It included uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA), manifest refraction, slit-lamp biomicroscopy, Goldman tonometry, scotopic pupil size measurement, corneal topography, ultrasound pachymetry, biometry, ocular wavefront aberrometry and funduscopy.

The following conditions were considered as exclusion criteria for surgery: estimated stromal residual bed thickness below 250 μm after programming the laser ablation, significant corneal topographic asymmetry, cataract, glaucoma, previous ocular surgery, keratoconus, and any active ocular disease. We only considered for the analysis those cases in which the target postoperative refraction had been emmetropia.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.